nach oben

Current Bladder Dysfunction Reports

Erschienen in:

15.11.2021 | BPS/Interstitial Cystitis (D Castro-Diaz and Y Igawa, Section Editors)

Role of Surgery in Bladder Pain Syndrome

verfasst von: O. A. Alsulaiman, S. Saad, N. I. Osman, C. R. Chapple

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Bladder pain syndrome is a clinical condition with many aspects to its presentation and numerous suggested treatments, many of which remain controversial. Reconstructive surgery should only be considered when all the conservative options have been exhausted and only after careful counselling. The purpose of this review is to demonstrate the current evidence in the surgical management of this disease, preparatory to which we have reviewed the surgical aspects.

Recent Findings

For medical treatment, the evidence base is of poor quality and based on case series. Nevertheless, in carefully selected patients after appropriate counselling, excellent results can be achieved both with total cystectomy and augmentation cystoplasty or a continent or incontinent diversion.

Summary

We reviewed the various success rates of the treatments which are described. A multidisciplinary approach is essential to a successful outcome, and it is essential to consider not only the urological, but also broader medical and psychological consequences seen with bladder pain syndrome. Further research should focus on clearly categorizing the patients with well-defined clinical criteria to provide high-quality evidence to support the selection of the most effective treatment.

•• Meijlink JM. Bladder pain: the patient perspective. Urologia. 2017;84(Suppl 1):5–7. https://doi.org/10.5301/uj.5000261 (This reference covers the important issue of covering the patient’s perspective in any treatment; this is essential for a successful outcome.).CrossRefPubMed

•• Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78. doi: https://doi.org/10.1002/nau.10052. As mentioned in the article, careful clarification of terminology and consensus relating to this is essential. This is a landmark article for the standardization of clinical conditions, allowing them to be adequately categorized and reported in the literature.

•• Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T, Wein A; Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Neurourol Urodyn. 2010;29(1):191–8. https://doi.org/10.1002/nau.20847. This important consensus update consolidates the views of a number of the key workers in the field relating to bladder pain syndrome.

•• van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P, Mortensen S, van Ophoven A, Osborne JL, Peeker R, Richter B, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7. https://doi.org/10.1016/j.eururo.2007.09.019 (This interesting article from ESSIC reports the European perspective relating to the management of bladder pain syndrome.).CrossRefPubMed

• Patnaik SS, Laganà AS, Vitale SG, Butticè S, Noventa M, Gizzo S, Valenti G, Rapisarda AMC, La Rosa VL, Magno C, Triolo O, Dandolu V. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet. 2017;295(6):1341–59. https://doi.org/10.1007/s00404-017-4364-2 (This is a review of the aetiology, pathophysiology, and biomarker use from a different perspective.).CrossRefPubMed

• Duncan JL, Schaeffer AJ. Do infectious agents cause interstitial cystitis? Urology. 1997;49(5A Suppl):48–51. https://doi.org/10.1016/s0090-4295(99)80331-8 (The potential role of infection in generating bladder pain syndrome is controversial and is addressed by this article.).CrossRefPubMed

• Peters KM, Killinger KA, Ibrahim IA. Childhood symptoms and events in women with interstitial cystitis/painful bladder syndrome. Urology. 2009;73(2):258–62. https://doi.org/10.1016/j.urology.2008.09.014 (This article considers lifelong problems relating to the genesis of bladder pain syndrome.).CrossRefPubMed

• Warren JW, Brown V, Jacobs S, Horne L, Langenberg P, Greenberg P. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology. 2008;71(6):1085–90. https://doi.org/10.1016/j.urology.2007.12.091 (A further article relating to the potential role of infective agents.).CrossRefPubMed

• Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol. 1991;145(4):732–5. https://doi.org/10.1016/s0022-5347(17)38437-9 (The potential role of a disorder of the lining of the urothelium being important in the potential pathogenesis of bladder pain syndrome.).CrossRefPubMed

10.

• Liu HT, Shie JH, Chen SH, Wang YS, Kuo HC. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome. Urology. 2012;80(1):225.e13-8. https://doi.org/10.1016/j.urology.2012.01.047 (Inflammatory changes are without doubt important in the genesis of bladder pain syndrome.).CrossRef

11.

• Zeng Y, Wu XX, Homma Y, Yoshimura N, Iwaki H, Kageyama S, Yoshiki T, Kakehi Y. Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis. J Urol. 2007;178(4 Pt 1):1322–7; discussion 1327. https://doi.org/10.1016/j.juro.2007.05.125. The mechanism of the urothelium is potentially important in the genesis of bladder pain syndrome.

12.

Simmons JL. Interstitial cystitis: an explanation for the beneficial effect of an anti-histamine. J Urol. 1961;85:149–55.CrossRef

13.

• Liu H-T, Jiang Y-H, Kuo H-C. Alteration of urothelial inflammation, apoptosis, and junction protein in patients with various bladder conditions and storage bladder symptoms suggest common pathway involved in underlying pathophysiology. Low Urin Tract Symptoms. 2015;7:102–7 (This article considers whether there is a common pathway in the development of bladder pain syndrome.).CrossRef

14.

• Akiyama Y, Maeda D, Morikawa T, et al. Digital quantitative analysis of mast cell infiltration in interstitial cystitis. Neurourol Urodyn. 2018;37:650–7 (An overview of the role of mast cells in the genesis of bladder pain syndrome.).CrossRef

15.

• Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol. 1999;161(2):553–7. https://doi.org/10.1016/s0022-5347(01)61948-7 (An early article underpinning current discussions.).CrossRefPubMed

16.

Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol. 1998;160(5):1663–7.CrossRef

17.

Walker SJ, Zambon J, Andersson KE, Langefeld CD, Matthews CA, Badlani G, Bowman H, Evans RJ. Bladder capacity is a biomarker for a bladder centric versus systemic manifestation in interstitial cystitis/bladder pain syndrome. J Urol. 2017;198(2):369–75. https://doi.org/10.1016/j.juro.2017.02.022.CrossRefPubMed

18.

Peters KM, Killinger KA, Mounayer MH, Boura JA. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions Urology. 2011;78(2):301–8. https://doi.org/10.1016/j.urology.2011.04.030.CrossRefPubMed

19.

Akiyama Y, Luo Y, Hanno PM, Maeda D, Homma Y. Interstitial cystitis/bladder pain syndrome: the evolving landscape, animal models and future perspectives. Int J Urol. 2020;27(6):491–503. https://doi.org/10.1111/iju.14229.CrossRefPubMedPubMedCentral

20.

•• Fall M, Nordling J, Cervigni M, Dinis Oliveira P, Fariello J, Hanno P, Kåbjörn-Gustafsson C, Logadottir Y, Meijlink J, Mishra N, Moldwin R, Nasta L, Quaghebeur J, Ratner V, Sairanen J, Taneja R, Tomoe H, Ueda T, Wennevik G, Whitmore K, Wyndaele JJ, Zaitcev A. Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report. Scand J Urol. 2020;54(2):91–8 (A recent paper questioning the current approach to the disease.).CrossRef

21.

Kivlin D, Lim C, Ross C, Whitmore K, Schellato T. The diagnostic and treatment patterns of urologists in the United States for interstitial cystitis/painful bladder syndrome. Urol Pract. 2016;3:309–14.CrossRef

22.

Engeler D, Baranowski AP, Borovicka J, et al. Chronic pelvic pain. Uroweb. http://uroweb.org/guideline/chronic-pelvic-pain/.

23.

Hanno PM, Erickson D, Moldwin R, Faraday MM; American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–53. https://doi.org/10.1016/j.juro.2015.01.086.

24.

Hamer AJ, Nicholson S, Padfield CJ. Spontaneous rupture of the bladder in interstitial cystitis. Br J Urol. 1992;69(1):102. https://doi.org/10.1111/j.1464-410x.1992.tb15474.x.CrossRefPubMed

25.

Olson LE, Dyer JE, Haq A, Ockrim J, Greenwell TJ. A systematic review of the literature on cystodistension in bladder pain syndrome. Int Urogynecol J. 2018;29(2):251–7. https://doi.org/10.1007/s00192-017-3355-y.CrossRefPubMed

26.

Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology. 2004;64(5):871–5; discussion 875. https://doi.org/10.1016/j.urology.2004.06.073.

27.

• Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int. 2009;104(5):657–61. https://doi.org/10.1111/j.1464-410X.2009.08495.x (RCT comparing different doses of BTA to hydrodistension alone.).CrossRefPubMed

28.

Kuo HC, Jiang YH, Tsai YC, Kuo YC. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn. 2016;35(5):609–14. https://doi.org/10.1002/nau.22760.CrossRefPubMed

29.

Lee CL, Kuo HC. Intravesical botulinum toxin A injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician. 2013;16(2):109–16.PubMed

30.

Pinto R, Lopes T, Costa D, Barros S, Silva J, Silva C, Cruz C, Dinis P, Cruz F. Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A. Urology. 2014;83(5):1030–4. https://doi.org/10.1016/j.urology.2014.01.018.CrossRefPubMed

31.

Fall M. Conservative management of chronic interstitial cystitis: transcutaneous electrical nerve stimulation and transurethral resection. J Urol. 1985;133(5):774–8. https://doi.org/10.1016/s0022-5347(17)49222-6.CrossRefPubMed

32.

Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(5):290–5. https://doi.org/10.1007/s001920070019.CrossRefPubMed

33.

Rofeim O, Hom D, Freid RM, Moldwin RM. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J Urol. 2001;166(1):134–6.CrossRef

34.

Irwin PP, Galloway NT. Surgical management of interstitial cystitis. Urol Clin North Am. 1994;21(1):145–51.CrossRef

35.

Redmond EJ, Flood HD. The role of reconstructive surgery in patients with end-stage interstitial cystitis/bladder pain syndrome: is cystectomy necessary? Int Urogynecol J. 2017;28(10):1551–6. https://doi.org/10.1007/s00192-017-3307-6.CrossRefPubMed

36.

•• Osman NI, Bratt DG, Downey AP, Esperto F, Inman RD, Chapple CR. A systematic review of surgical interventions for the treatment of bladder pain syndrome/interstitial cystitis. Eur Urol Focus. 2020;S2405–4569(20):30071–7. https://doi.org/10.1016/j.euf.2020.02.014 (Interesting paper in which the author reviewed the data for major surgical interventions.).CrossRef

37.

Kim HJ, Lee JS, Cho WJ, Lee HS, Lee HN, You HW, Jung W, Lee KS. Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner’s lesion. Int J Urol. 2014;21(Suppl 1):69–73. https://doi.org/10.1111/iju.12320.CrossRefPubMed

38.

Nurse DE, McCrae P, Stephenson TP, Mundy AR. The problems of substitution cystoplasty. Br J Urol. 1988;61(5):423–6. https://doi.org/10.1111/j.1464-410x.1988.tb06589.x.CrossRefPubMed

39.

Linn JF, Hohenfellner M, Roth S, Dahms SE, Stein R, Hertle L, Thüroff JW, Hohenfellner R. Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution. J Urol. 1998;159(3):774–8. https://doi.org/10.1016/s0022-5347(01)63726-1.CrossRefPubMed

40.

Downey, A., Osman, N.I., Parks, J.J., Mangera, A., Inman, R.D., Reid, S.V., Chapple, C.R., 2020. Contemporary outcomes of surgery for bladder pain syndrome/interstitial cystitis. European Urology Open Science 19, e498. doi;/https://doi.org/10.1016/S2666-1683(20)32899-8

41.

Nordling J, Blaivas JG. Should urinary diversion for bladder pain syndrome/interstitial cystitis include cystectomy? No J Urol. 2014;191(2):293–5. https://doi.org/10.1016/j.juro.2013.11.024.CrossRefPubMed

42.

Freiha FS, Faysal MH, Stamey TA. The surgical treatment of intractable interstitial cystitis. J Urol. 1980;123(5):632–4. https://doi.org/10.1016/s0022-5347(17)56070-x.CrossRefPubMed

Titel: Role of Surgery in Bladder Pain Syndrome
verfasst von: O. A. Alsulaiman
S. Saad
N. I. Osman
C. R. Chapple
Publikationsdatum: 15.11.2021
Verlag: Springer US
Erschienen in: Current Bladder Dysfunction Reports / Ausgabe 4/2021
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-021-00636-1

Neu im Fachgebiet Urologie

22.04.2024 | Prostatakarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Role of Surgery in Bladder Pain Syndrome

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Urologie

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Urologie

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Urologie